Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 175,000 shares at $18.00 ($3.1M) on 2021-03-08, disclosed to the SEC on 2021-03-09.
Seasonal sale ($3.1M) by President and CEO — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| VNDA | BUY | 2025-05-21 | $44K | — | Filing → |
| VNDA | BUY | 2025-05-19 | $84K | — | Filing → |
| VNDA | BUY | 2025-03-06 | $50K | — | Filing → |